Targeting alternative splicing as a new cancer immunotherapy-phosphorylation of serine arginine-rich splicing factor (SRSF1) by SR protein kinase 1 (SRPK1) regulates alternative splicing of PD1 to generate a soluble antagonistic isoform that prevents T cell exhaustion
Titel:
Targeting alternative splicing as a new cancer immunotherapy-phosphorylation of serine arginine-rich splicing factor (SRSF1) by SR protein kinase 1 (SRPK1) regulates alternative splicing of PD1 to generate a soluble antagonistic isoform that prevents T cell exhaustion
Auteur:
Wahid, Mussarat Pratoomthai, Benjamart Egbuniwe, Isioma U. Evans, Hannah R. Babaei-Jadidi, Roya Amartey, Jason O. Erdelyi, Viola Yacqub-Usman, Kiren Jackson, Andrew M. Morris, Jonathan C. Patel, Poulam M. Bates, David O.